Displaying 1 - 4 of 4
Active Ingredient BIMATOPROST
Therapeutic Class EENT PROSTAGLANDIN ANALOGS
Indications Glaucoma, ocular hypertension.
Caution Conjunctival hyperemia, iris pigmentation, and eyelid/eyelash changes, glaucoma.
Dose Range 1 drop once daily . See BDS supply protocols pg. 11.
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient LATANOPROST
Therapeutic Class EENT PROSTAGLANDIN ANALOGS
Indications Latanoprost ophthalmic solution has effectively lowered intraocular
pressure in ocular hypertension, primary open-angle glaucoma, and capsular glaucoma, and has produced additive effects with ophth More ...
Caution Mild conjunctival hyperemia and local irritation, iris pigmentation can occur during long-term therapy and has resulted in drug discontinuation.
Dose Range 1 drop preferably in the evening once daily . See BDS supply protocols pg. 11.
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient TAFLUPROST
Therapeutic Class EENT PROSTAGLANDIN ANALOGS
Indications Raised intra-ocular pressure in open-angle glaucoma; ocular hypertension.
Caution Ocular irritation and pain, conjunctival hyperemia, dry eye, headache.
Dose Range Once daily preferably in the evening.
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient TRAVOPROST
Therapeutic Class EENT PROSTAGLANDIN ANALOGS
Indications Indicated primarily in patients with ocular hypertension or open-angle glaucoma who are unresponsive to or intolerant of other topical antiglaucoma agents. It appears at least as effe More ...
Caution Conjunctival hyperemia, reduced visual acuity , eye discomfort or pain, and ocular pruritus. An increase in iris pigmentation (brown) occurs in up to 5% of patients; increased eyelid pigmentation and More ...
Dose Range 1 drop once daily . See BDS supply protocols pg. 11.
Drug Interactions
Pregnancy
Breast Feeding